首页> 外国专利> METHOD FOR ASSESSING THE SEVERITY OF GASTRIC ULCER WITH ULCER LOCALIZATION IN THE ANTRUM ASSOCIATED WITH HELICOBACTER PYLORI AND EPSTEIN-BARR VIRUS

METHOD FOR ASSESSING THE SEVERITY OF GASTRIC ULCER WITH ULCER LOCALIZATION IN THE ANTRUM ASSOCIATED WITH HELICOBACTER PYLORI AND EPSTEIN-BARR VIRUS

机译:评估胃溃疡严重程度具有溃疡定位的胃溃疡与幽门螺杆菌和爱泼斯坦 - 巴克病毒相关的溃疡定位

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, in particular to gastroenterology. The substance of the invention lies in the fact that in patients with gastric ulcer with the localization of ulcers in the antrum of the stomach associated with Helicobacter pylori (H. pylori) and Epstein-Barr virus (EBV), not only H. pylori contamination of the gastric mucosa is assessed, but also using the polymerase chain reaction method, the number of EBV copies is detected per 105 cells of the infiltrate. When detecting the number of EBV copies from 10001 or more per 105 cells of the infiltrate, the severity of the course of the disease is assessed as severe. If the number of EBV copies is found from 1001 to 10,000 per 105 cells of the infiltrate, the severity of the course of the disease is assessed as average. If the number of EBV copies is found from 101 to 1000 per 105 cells of the infiltrate, the severity of the course of the disease is assessed as mild. If the number of EBV copies is detected up to 100 per 105 cells of the infiltrate, the treatment of the Epstein-Barr virus is carried out as if the severity of the disease was mild. Subject to the presentation of complaints and the detection of gastric ulcer or a picture of pronounced antral gastritis during fibrogastroduodenoscopy, in other cases, treatment of the Epstein-Barr virus is not required.;EFFECT: invention provides an increase in the efficiency of diagnostics of the course of gastric ulcer with ulcer localization in the antrum of the stomach associated with H. pylori and EBV, timely predicting the course of the disease and optimizing the treatment of patients, reducing the number of exacerbations.;1 cl, 1 tbl, 5 ex
机译:田地:医学。物质:发明涉及药物,尤其涉及胃肠病学。本发明的物质在于胃溃疡患者患者患有溃疡中的胃中的胃窦(H. Pylori)和Epstein-Barr病毒(EBV)的患者,不仅是H.幽门螺杆菌污染评估胃粘膜,还使用聚合酶链式反应方法,每105个渗透的细胞检测EBV拷贝的数量。当每105个细胞的浸润的10001或更多或更多的EBV拷贝数量检测到每105个细胞时,疾病过程的严重程度被评估为严重。如果EBV拷贝的数量从1001次渗透到每105个细胞中发现1001至10,000份,则疾病过程的严重程度为平均评估。如果EBV拷贝的数量从105个细胞的渗透剂中发现101至1000个,则疾病过程的严重程度被评估为温和。如果每105个细胞的渗透性检测到eBV拷贝的数量,则进行Epstein-Barr病毒的治疗,好像疾病的严重程度轻度。在介绍抱怨和胃溃疡的检测或纤维动物溃疡内的胃溃疡图像的情况下,在其他情况下,不需要治疗Epstein-Barr病毒。;效果:发明诊断效率的增加胃溃疡溃疡溃疡患者患有胃窦的胃窦,与H. pylori和EBV相关,及时预测疾病的过程,优化患者的治疗,减少加剧的数量。; 1 Cl,1 Tbl,5前任

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号